Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000579242 | SCV000681213 | likely pathogenic | not provided | 2017-12-07 | criteria provided, single submitter | clinical testing | The c.1528-1G>A variant in the PIEZO2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This splice site variant destroys the canonical splice acceptor site in intron 12. It is predicted to cause abnormal gene splicing resulting in an in-frame protein product with an abnormal message. The c.1528-1G>A variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1528-1G>A as a likely pathogenic variant. |
Undiagnosed Diseases Network, |
RCV000625966 | SCV000746564 | likely pathogenic | Arthrogryposis, distal, with impaired proprioception and touch | 2017-12-11 | criteria provided, single submitter | clinical testing | This splice site mutation is categorized as deleterious according to ACMG guidelines (PMID: 18414213) and was found in trans with another variant (c.5083-1G>A) in a 6-year-old female with ataxia, hypotonia, mild dysmorphic features, delayed motor development, scoliosis. It is predicted to cause abnormal gene splicing resulting in an in-frame protein product with an abnormal message. |